Valuation: Acotec Scientific Holdings Limited

Capitalization 2.46B 2.84B 362M 309M 283M 268M 497M 34.68B 502M 3.38B 1.31B 16.45B 1.36B 1.33B 57.15B P/E ratio 2026 *
18.3x
P/E ratio 2027 * 14.5x
Enterprise value 2.46B 2.84B 362M 309M 283M 268M 497M 34.68B 502M 3.38B 1.31B 16.45B 1.36B 1.33B 57.15B EV / Sales 2026 *
3.38x
EV / Sales 2027 * 2.7x
Free-Float
16.21%
Yield 2026 *
-
Yield 2027 * -
1 day-3.62%
1 week-4.54%
Current month-4.74%
1 month-28.12%
3 months-36.22%
6 months-26.42%
Current year-32.96%
1 week 8.83
Extreme 8.83
9.61
1 month 8.83
Extreme 8.83
12.65
Current year 8.83
Extreme 8.83
15.32
1 year 7.07
Extreme 7.07
15.47
3 years 5.26
Extreme 5.26
17
5 years 4.21
Extreme 4.21
19.88
10 years 4.21
Extreme 4.21
19.88
Manager TitleAgeSince
Chief Executive Officer 54 28/01/2021
Chief Tech/Sci/R&D Officer 48 28/01/2021
Chief Tech/Sci/R&D Officer 85 28/01/2021
Director TitleAgeSince
Chairman 54 28/01/2021
Director/Board Member 56 02/12/2020
Director/Board Member 79 28/01/2021
Change 5d. change 1-year change 3-years change Capi.($)
-3.62%-4.54%+14.99%-40.15% 376M
+0.34%-0.33%+8.48%+0.73% 12.65B
+0.03%-0.02%+9.16%+3.43% 9.35B
+0.16%+4.74%-1.83%-23.13% 5.63B
+1.04%-0.48%+45.85%+28.09% 5.62B
+1.96%-0.96%-14.39%+40.79% 4.78B
-1.09%+1.95%-16.03%-8.21% 4.43B
+6.54%+1.80% - - 3.13B
+1.16%+15.30%-1.40%-75.59% 2.1B
-2.68%+1.62%+5.63%-42.89% 1.7B
Average +0.39%+1.25%+5.61%-12.99% 4.98B
Weighted average by Cap. +0.67%+1.19%+6.70%-0.41%

Financials

2026 *2027 *
Net sales 728M 839M 107M 91.42M 83.84M 79.36M 147M 10.26B 148M 999M 389M 4.87B 402M 394M 16.91B 910M 1.05B 134M 114M 105M 99.2M 184M 12.82B 186M 1.25B 486M 6.08B 503M 492M 21.13B
Net income 128M 148M 18.85M 16.07M 14.74M 13.95M 25.86M 1.8B 26.11M 176M 68.37M 856M 70.72M 69.23M 2.97B 164M 189M 24.15M 20.59M 18.89M 17.88M 33.13M 2.31B 33.45M 225M 87.6M 1.1B 90.61M 88.7M 3.81B
Net Debt - -
Logo Acotec Scientific Holdings Limited
Acotec Scientific Holdings Ltd is a company engaged in interventional medical device business. The Company is primarily engaged in the research and development on providing treatment solutions for vascular diseases, involving drug-coated balloons (DCB) and percutaneous transluminal angioplasty balloon catheters (PTA). The Company’s main products include AcoArt Orchid & Dhalia, AcoArt Tulip & Litos, AcoArt Iris & Jasmin, AcoArt Lily & Rosmarin, Peripheral Aspiration System (AcoStream), Radiofrequency Ablation System (AcoArt Cedar), 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream) and others, covering fields such as vascular surgery, cardiology, nephrology and neurology. The Company conducts its businesses within domestic and overseas markets.
Employees
653
Date Price Change Volume
12/05/26 9.050 $ -3.62% 278,510
11/05/26 9.390 $ +0.21% 295,525
08/05/26 9.370 $ +4.23% 342,975
07/05/26 8.990 $ +0.90% 338,465
06/05/26 8.910 $ -6.01% 314,162
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.852CNY
Average target price
15.00CNY
Spread / Average Target
+91.00%

Annual profits - Rate of surprise